New Century Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25,091
Closed -$1.16M 74
2025
Q2
$1.16M Buy
+25,091
New +$1.23M 1.36% 26
2024
Q3
Sell
-21,234
Closed -$882K 315
2024
Q2
$882K Buy
21,234
+296
+1% +$13.2K 0.37% 73
2024
Q1
$1.14M Buy
+20,938
New +$1.07M 0.79% 33

Other funds holding BMY

New Century Financial Group's BMY Position: Q3 2025 in Review

New Century Financial Group sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 25,091 shares — an estimated $1.16M sold.

New Century Financial Group first reported a position in BMY in Q1 2024 and held it in 3 quarters. The position peaked at $1.16M in Q2 2025. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • New Century Financial Group reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • New Century Financial Group sold 25,091 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.16M.
  • New Century Financial Group first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 3 quarters.
  • New Century Financial Group's Bristol-Myers Squibb position peaked at $1.16M in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on New Century Financial Group's 13F filing for Q3 2025, filed 22 Oct 2025.